Fig. 7From: Gauging innovation and health impact from biomedical research: survey results and interviews with recipients of EU-funding in the fields of Alzheimer’s disease, breast cancer and prostate cancerA Contribution of complex in vitro models (e.g., 3D models, spheroids, organoids, microfluidic, organ/tissue on chips, etc.) to gaining impact. B Contribution of in silico models (in silico/computational models) to gaining impact. Values are expressed as percentages of respondents who considered these models as essential to the success of their projectBack to article page